Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis.

Antonio Giovanni SolimandoNicola SuscaAntonella ArgentieroOronzo BrunettiPatrizia LeoneValli De ReRossella FasanoMarkus KrebsElisabetta PetracciIrene AzzaliOriana NanniNicola SilvestrisAngelo VaccaVito Racanelli

Published in: Clinical and experimental medicine (2021)

The results of this network meta-analysis suggest the use of regorafenib and cabozantinib as second-line treatments in HCC.

Keyphrases

systematic review
meta analyses
case control
randomized controlled trial